Photodynamic therapy vs. cryotherapy for actinic keratoses

August 27, 2014, The JAMA Network Journals

Photodynamic therapy (PDT, which uses topical agents and light to kill tissue) appears to better clear actinic keratoses (AKs, a common skin lesion caused by sun damage) at three months after treatment than cryotherapy (which uses liquid nitrogen to freeze lesions).

AKs are rough, scaly on the skin typically found on individuals with fair complexions who have had lots of sun exposure. The lesions have the potential to become cancer. PDT is an increasingly popular treatment.

The authors compared PDT with cryotherapy in a meta-analysis of four studies that included 641 patients with a total of 2,174 AKs treated with cryotherapy and 2,170 lesions treated with PDT.

Patients treated with PDT had a 14 percent better chance of complete lesion clearance at three months after treatment than cryotherapy for thin AKs on the face and scalp.

"An analysis of the effectiveness of PDT compared with other treatments may help physicians decide what role it should play in their own clinical practice." Gayatri Patel, M.D., M.P.H., of the University of California Davis Medical Center, in Sacramento, and colleagues said in their JAMA Dermatology article.

In a related editorial, Harvey Lui, M.D., F.R.C.P.C., of the University of British Columbia, writes: "Notwithstanding the apparent superiority of PDT to cryotherapy, the light-based approach to treating AK has three major limitations. The current financial remuneration model is a major disincentive. … Although PDT appears to be a simple concept, in practice optimal results may require longer drug incubation times and perhaps light-dose fractionation to generate a sufficient tissue effect. … Finally, local pain owing to photosensitizer activation during light exposure is perhaps the most striking adverse effect that clinicians need to anticipate and manage during PDT."

"All three of these limiting factors necessitate added time and resources compared with the relatively brief outpatient visits for , in which is simply and efficiently dispensed to the skin," Lui notes.

Explore further: Common therapies for basal cell carcinoma offer similar survival

More information: JAMA Dermatology. Published online August 27, 2014. DOI: 10.1001/jamadermatol.2014.1253
JAMA Dermatology. Published online August 27, 2014. DOI: 10.1001/jamadermatol.2014.1869

Related Stories

Common therapies for basal cell carcinoma offer similar survival

May 25, 2012
(HealthDay) -- For patients with superficial basal cell carcinoma (sBCC), treatment with imiquimod or photodynamic therapy (PDT) results in similar long-term tumor-free survival, according to a review published online May ...

An easier, safer, and more accurate treatment for pancreatic cancer

April 2, 2014
Using CT scans with contrast enhancement, Dartmouth researchers measured treatment response to pancreatic cancer photodynamic therapy (PDT) according to a paper published in Physics in Medicine and Biology.

Biochips for better cancer therapy

February 25, 2014
Cancer is the second leading cause of disease-related death in the United States, and may overtake heart disease without aggressive new therapies. One promising area of cancer treatment is photodynamic therapy (PDT), which ...

Multimodal palliative approach OK for advanced esophageal CA

February 27, 2012
(HealthDay) -- For patients with advanced esophageal cancer, use of an individualized, multimodal approach with palliative intention achieves an acceptable mean survival time, with initial use of photodynamic therapy (PDT) ...

Light dynamics for cancer treatment

May 3, 2012
Research is delving into refinement of a revolutionary cancer treatment, photodynamic therapy (PDT). Using light, reactive oxygen and photosensitisers linked to specially designed antibodies, scientists are on the threshold ...

Recommended for you

New study validates clotting risk factors in chronic kidney disease

January 17, 2018
In late 2017, researchers from Boston University School of Medicine (BUSM) discovered and published (Science Translational Medicine, (9) 417, Nov 2017) a potential treatment target to prevent chronic kidney disease (CKD) ...

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...

Fresh approach to tuberculosis vaccine offers better protection

January 17, 2018
A unique platform that resulted in a promising HIV vaccine has also led to a new, highly effective vaccine against tuberculosis that is moving toward testing in humans.

Newly-discovered TB blood signal provides early warning for at-risk patients

January 17, 2018
Tuberculosis can be detected in people with HIV infection via a unique blood signal before symptoms appear, according to a new study by researchers from the Crick, Imperial College London and the University of Cape Town.

New study offers insights on genetic indicators of COPD risk

January 16, 2018
Researchers have discovered that genetic variations in the anatomy of the lungs could serve as indicators to help identify people who have low, but stable, lung function early in life, and those who are particularly at risk ...

Previous influenza virus exposures enhance susceptibility in another influenza pandemic

January 16, 2018
While past exposure to influenza A viruses often builds immunity to similar, and sometimes different, strains of the virus, Canadian researchers are calling for more attention to exceptions to that rule.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.